Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel catalytic route for cis-bicyclo [3.1.0] hex-3-ol reduces cost and improves safety for pharmaceutical intermediates manufacturing supply chains.
Patent CN104072500A details a novel synthesis for quinoxaline imidazolium salts. This route offers significant supply chain stability and cost reduction in catalyst ligand manufacturing for global partners.
Patent CN110590644B details a metal-free one-pot cascade method for chiral 1,2-dihydropyridines, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Pd-catalyzed route for cis-fused beta-lactam compounds. Enhances supply chain reliability and reduces manufacturing costs for antibiotic intermediates.
Novel silver triflate method improves yield and stability for high-purity pharmaceutical intermediates supply chain optimization.
Novel Leuckart reaction route improves yield and purity for Alzheimer's drug intermediates, offering cost-effective manufacturing solutions.
Patent CN106278965B details a copper-catalyzed method for aryl-alkyl asymmetric persulfides. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.
Novel route for Dapoxetine HCl using chiral organocatalyst. High yield, >99% ee. Ideal for API intermediates and cost reduction in pharmaceutical manufacturing.
Patent CN112679336A reveals a green heterogeneous Pd@POL catalytic route for phenylpropionic acids, offering reduced heavy metal residues and enhanced supply chain reliability for pharmaceutical intermediates.
Patent CN107311959A details a green iodine-catalyzed route for 2-aminobenzothiazoles, offering cost reduction and scalable manufacturing for pharmaceutical intermediate suppliers.
Patent CN102875444A details a Cu-catalyzed route for oxindoles. Offers high purity, mild conditions, and scalable manufacturing for pharma intermediates.
Patent CN110256211B reveals a photoredox method for 1,1-diarylalkane derivatives. Offers mild conditions and cost reduction in fine chemical manufacturing for global supply chains.
Patent CN101402582A reveals a novel one-step four-component reaction for high-purity pharmaceutical intermediates. This method significantly reduces cost and improves supply chain reliability.
Patent CN114507180A reveals an iodine-catalyzed method for synthesizing bis-heteroaryl ethylenes with 90% yield, offering a metal-free route for reliable pharmaceutical intermediate suppliers.
Patent CN114634481B reveals copper-mediated method improving substrate scope. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN114315906B discloses novel chiral phosphite ligands enabling high-yield asymmetric hydrosilylation and hydroformylation for reliable pharmaceutical intermediate supplier networks.
Patent CN105085419A details novel catalytic method ensuring high purity and scalable production for reliable pharmaceutical intermediate supply chains globally.
Patent CN115850240B reveals a two-step route for Olutasidenib. This method ensures high purity and supply chain stability for pharmaceutical manufacturers.
Patent CN108752290B details a high-yield TTP/HFIP catalytic route for benproperine phosphate, offering significant cost reduction and purity improvements for API manufacturers.
Patent CN103214407B details silver-catalyzed sp3 C-H amination for tetrahydropyrrole derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.